# Drdgold Ltd: financial statements, quarterly

DRD · NYSE · CIK 1023512 · [Materials](/sectors/materials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/drd.md) · [Financials](/companies/drd/financials.md) · [Filings](/companies/drd/filings.md) · [Insiders](/companies/drd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/drd/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-06-30) | period not labelled (2016-06-30) | period not labelled (2017-06-30) | FY2018 (2018-06-30) | period not labelled (2019-06-30) | FY2020 (2020-06-30) | FY2021 (2021-06-30) | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001023512-18-000010.md) | [0.4](/filings/0001023512-18-000010.md) | [0.3](/filings/0001023512-20-000018.md) | [0.3](/filings/0001562762-21-000379.md) | [0.3](/filings/0001562762-22-000397.md) | [1.7](/filings/0001023512-23-000062.md) | [2.2](/filings/0001023512-24-000052.md) | [2.5](/filings/0001628280-25-047346.md) | [2.5](/filings/0001628280-25-047346.md) | [0.5](/filings/0001628280-25-047346.md) | [1.3](/filings/0001628280-25-047346.md) |
| Current assets | $bn | not reported | not reported | [0.5](/filings/0001023512-18-000010.md) | [0.6](/filings/0001023512-18-000010.md) | [0.7](/filings/0001023512-20-000018.md) | [2.2](/filings/0001562762-21-000379.md) | [2.7](/filings/0001562762-22-000397.md) | [3.1](/filings/0001023512-23-000062.md) | [3.2](/filings/0001023512-24-000052.md) | [1.5](/filings/0001628280-25-047346.md) | [2.3](/filings/0001628280-25-047346.md) |
| Total assets | $bn | not reported | not reported | [2.3](/filings/0001023512-18-000010.md) | [2.4](/filings/0001023512-18-000010.md) | [4.1](/filings/0001023512-20-000018.md) | [5.7](/filings/0001562762-21-000379.md) | [6.3](/filings/0001562762-22-000397.md) | [7.1](/filings/0001023512-23-000062.md) | [8.2](/filings/0001023512-24-000052.md) | [9.5](/filings/0001628280-25-047346.md) | [12.2](/filings/0001628280-25-047346.md) |
| Current liabilities | $bn | not reported | not reported | [0.3](/filings/0001023512-18-000010.md) | [0.3](/filings/0001023512-18-000010.md) | [0.5](/filings/0001023512-20-000018.md) | [0.7](/filings/0001562762-21-000379.md) | [0.5](/filings/0001562762-22-000397.md) | [0.6](/filings/0001023512-23-000062.md) | [0.7](/filings/0001023512-24-000052.md) | [1.0](/filings/0001628280-25-047346.md) | [1.0](/filings/0001628280-25-047346.md) |
| Total liabilities | $bn | not reported | not reported | [1.0](/filings/0001023512-18-000010.md) | [1.1](/filings/0001023512-18-000010.md) | [1.4](/filings/0001023512-20-000018.md) | [1.6](/filings/0001562762-21-000379.md) | [1.5](/filings/0001562762-22-000397.md) | [1.6](/filings/0001023512-23-000062.md) | [1.9](/filings/0001023512-24-000052.md) | [2.6](/filings/0001628280-25-047346.md) | [3.4](/filings/0001628280-25-047346.md) |
| Shareholders' equity | $bn | [1.5](/filings/0001023512-18-000010.md) | [1.3](/filings/0001023512-18-000010.md) | [1.3](/filings/0001023512-20-000018.md) | [1.3](/filings/0001562762-21-000379.md) | [2.7](/filings/0001562762-22-000397.md) | [4.0](/filings/0001023512-23-000062.md) | [4.8](/filings/0001023512-24-000052.md) | [5.4](/filings/0001628280-25-047346.md) | [6.3](/filings/0001628280-25-047346.md) | [6.9](/filings/0001628280-25-047346.md) | [8.9](/filings/0001628280-25-047346.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 867,397,699 at 2026-06-30, from the cover of the [20-F filed 2026-10-02](/filings/0001628280-26-064355.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.